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Abstract
Whole-genome sequencing (WGS) is becoming a fast and cost-effective method to pinpoint molecular lesions in
mutagenized genetic model systems, such as Caenorhabditis elegans. As mutagenized strains contain a significant mutational
load, it is often still necessary to mapmutations to a chromosomal interval to elucidate which of the WGS-identified sequence
variants is the phenotype-causing one. We describe here our experience in setting up and testing a simple strategy that
incorporates a rapid SNP-based mapping step into the WGS procedure. In this strategy, a mutant retrieved from a genetic
screen is crossed with a polymorphic C. elegans strain, individual F2 progeny from this cross is selected for the mutant
phenotype, the progeny of these F2 animals are pooled and then whole-genome-sequenced. The density of polymorphic
SNP markers is decreased in the region of the phenotype-causing sequence variant and therefore enables its identification in
the WGS data. As a proof of principle, we use this strategy to identify the molecular lesion in a mutant strain that produces an
excess of dopaminergic neurons. We find that the molecular lesion resides in the Pax-6/Eyeless ortholog vab-3. The strategy
described here will further reduce the time between mutant isolation and identification of the molecular lesion.
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Introduction
Whole-genome sequencing (WGS) is a new and powerful means
to identify molecular lesions that result in specific mutant
phenotypes [1,2]. The WGS approach has been used in several
studies in multiple model organisms, and our laboratory has
successfully employed this strategy in the nematode C. elegans [3,4,5].
Sequenced genomes of mutagenized strains contain a substantial
number of variants (on average more than 300 variants per
chromosome, about 30 of which are in protein coding sequences)
and a significant number of variants remain after outcrossing and/
or may even be introduced by outcrossing [5]. Identification of the
phenotype-causing mutation among the entire complement of
sequence variants can be significantly facilitated by whole genome
sequencing of two distinct alleles of the same locus. In such cases,
little if any mapping is required since the phenotype-causing mutant
locus will be one of the few, if not only loci found to be mutated in
both WGS datasets. However, to avoid multiple WGS runs and/or
if multiple alleles are not available, it may be desirable to first map
the phenotype-causing variant to a chromosomal interval. The most
commonly used mapping strategy in C. elegans employs single
nucleotide polymorphism (SNP)-based mapping [6,7,8]. In this
strategy, a mutant strain (usually derived from N2 Bristol) is crossed
with a polymorphic Hawaiian C. elegans isolate and the mutant F2
progeny of such a cross are analyzed for their distribution of SNP
markers. Genomic regions close to the mutation of interest show a
decreased incidence of Hawaiian SNPs while unlinked regions
contain an even representation of Hawaiian vs. Bristol SNPs.
However, this conventional SNP mapping strategy usually starts
with a relatively small, arbitrarily chosen number of SNPs. Through
re-iterative SNP mapping to finer and finer regions, the gene can be
fine-mapped, but this can be a relatively tedious and time-
consuming process. We describe here the employment of a strategy
- modeled on a similar strategy (‘‘SHOREmap’’) previously
employed in plants [9] - that combines WGS with a very fine-
grained SNP mapping strategy in a single step. This combination
significantly reduces the time between mutant isolation and
identification of its molecular identity.
Results
Overall strategy
The overall strategy is schematically depicted in Fig. 1. A
mutant strain, for which no mapping information is available, is
crossed with the polymorphic Hawaiian strain CB4856 [10] and a
number of F2 progeny that carry the mutant phenotype are
singled onto fresh plates. Each of the isolated F2 animals
represents a recombinant in which the Hawaiian chromosomes
have recombined with wild-type, Bristol-derived chromosomes.
The progeny of these singled F2 hermaphrodite animals ( = F3 and
F4 generation) are then pooled, DNA is prepared and the entire
pool is subjected to WGS.
Due to meiotic recombination, in regions unlinked to the
mutation the parental chromosomes will recombine in a largely
non-biased manner. So as long as enough recombinants are
pooled, unlinked SNP loci will appear in a roughly 50/50 ratio of
Hawaiian vs. Bristol nucleotides in the sequence output pileup
generated by the genome sequencer (Fig. 1). In contrast, the
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closer a SNP locus is to the mutation, the more rare it is to find a
recombination event between that SNP and the mutation (Fig. 1).
As a result, Hawaiian variants in the sequence pileup will be
underrepresented in regions closer to the selected mutation.
Finally, we expect to have only Bristol sequences in the sequence
pileup very near the mutation. Identifying an extended region of
pure Bristol sequence in such an approach is meaningful, since
Hawaiian SNPs are uniformly distributed across all chromosomes
with an average density of about 1/1,000 [11].
The WGS dataset is analyzed using a software tool that we
recently developed, called MAQGene [12]. We modified MAQ-
Gene to now perform two different functions: (i) it performs the
conventional function of identifying homozygous variants of non-
SNP loci between the mutant strain and the reference Bristol
genome; (ii) it now also considers the ratios of Hawaiian vs. Bristol
representation in the pileup at all known SNP loci in the genome
(,100,000 variants)[11]. Therefore, the same dataset originating
from a single WGS run for a given mutant will not only reveal the
SNP distribution but will also greatly improve the ability to identify
the phenotype-causing mutation, which will be one of the few -if not
the only- variants in an interval defined by the SNP mapping.
A key advantage of this strategy is that rather than examining an
arbitrarily chosen, limited number of SNPs to assess the map
position of a specific mutation (usually at most a few dozen [6]),
this strategy interrogates in a single step, at least in theory, all
,100,000 SNPs that distinguish the Hawaiian C. elegans isolate
from the Bristol isolate. Therefore, the WGS-SNP combination
not only eliminates all technical aspects of SNP mapping (PCR,
sequencing or restriction mapping of PCR amplicons), but also
provides, in one step, a much finer grained resolution. Moreover,
it reduces the costs of mutant identification, since it employs a
single whole-genome sequencing run for both mutant mapping as
well as mutant identification.
Proof of principle
We used this strategy to identify the molecular lesion in a
previously uncharacterized mutant strain that carries the ot266
allele. ot266 is a recessive mutation that we isolated in a screen for
mutants with defective dopaminergic neuron specification
(‘‘Dopy:’’ phenotype), as assessed by expression of the dopami-
nergic marker dat-1::gfp (expressed from the transgene vtIs1)[13].
ot266 mutants display an aberrantly increased number of
Figure 1. Principle of the WGS-SNP strategy. The red diamond indicates the mutation of interest. The sequence ‘pileup’, generated by
processing the WGS sequencing data, is a representation of the number of reads that are mapped to a specific position in the genome. The relative
number of N2 vs. Hawaiian nucleotides is a reflection of the relative distribution of recombinants in the pool.
doi:10.1371/journal.pone.0015435.g001
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dopaminergic neurons (Fig. 2A; Table 1). We crossed ot266; vtIs1
animals with the Hawaiian CB4856 strain and singled F2 progeny
with the Dopy phenotype. To assess how many recombinants are
required to yield reliable results, we pooled in one experiment the
progeny of 20 F2 animals and in another experiment the progeny
of 50 F2 animals. The pooled DNA from each experiment was
then subjected to WGS on an Illumina GA2 sequencing platform,
using single end, 100 nucleotide reads. One or two lanes of a flow
cell were used to assess the effect of various sequencing depths on
mapping resolution (Table 2).
As mentioned above, we modified MAQGene to provide an
additional output file with the sequence pileup at all Hawaiian/
Bristol polymorphic positions and the relative frequency of
Hawaiian and Bristol sequences at these positions. We extracted
from the list of SNPs those loci that had sufficient coverage and
whose pileup showed a defined proportion of Hawaiian sequences
(for the exact filtering criteria and data processing see Materials and
Methods). Graphs showing the distribution of those SNPs on the 6
chromosomes were then generated. We expected the mutation-
bearing region would be revealed by the lack of such Hawaiian
SNPs. The results are depicted in Fig. 3 and Table 2. An
alternative graphic representation of the data is shown in Fig. 4.
Through the dip in the distribution of Hawaiian SNPs, the ‘‘50
F2 pooled’’ dataset (2 lanes sequenced) defined a mapping interval
of 2.1 megabases (Mb) or 2.34 map units on the X chromosome
(Fig. 3; Table 2). To test the effect of coverage on the resolution of
the method, we analyzed the data from each of the two lanes of the
flow cell, one at a time. These datasets define a mapping interval of
2.06 Mb for one of the two lanes and 2.85 Mb for the other (Fig. 3;
Table 2; the reason for these interval sizes being different may be a
consequence of differential sample representation in the flow cell).
The sequence data from the progeny of 20 F2 recombinants (1 lane
sequenced) defined a mapping interval of 4.9 Mb (Fig. 3, Table 2).
We then used the MAQGene variant output file to find the
homozygous Bristol variants that fall in the defined mapping
interval (see Materials and Methods for variant filtering). The
smallest interval defined by SNP mapping (2.06 Mb) contained
only 3 protein-coding sequence variants (Table 2 and Table S1).
One of the three variants is a premature stop codon (Q338Stop) in
the vab-3 locus (Fig. 2B), which codes for the sole Pax6/Eyeless
homolog of C. elegans [14]. Our genetic screen uncovered one more
allele with a similar Dopy phenotype (ot292)(Table 1) and the
same morphological abnormalities as ot266 animals. Manual
Sanger-sequencing of that additional allele also identified a
premature stop codon in the vab-3 locus (W160Stop)(Fig. 2B).
In addition, the ot266 phenotype is recapitulated by the vab-3
reference allele e648 and by knockdown of vab-3 with RNAi
(Table 1). We conclude that vab-3 is involved in controlling the
generation of dopaminergic neurons. We note that a third,
previously identified vab-3 allele also shows a Dopy phenotype, yet
unlike the alleles described here, this allele has an additional
phenotype, i.e. partial loss of DA neurons [13].
Discussion
We have successfully applied a SNP- and WGS-based cloning
strategy for mutant identification in C.elegans. This strategy has
already been successfully employed in Arabidopsis thaliana [9]. For
the Arabidopsis study, 500 recombinants were used and sequencing
was done with single run reads to a coverage of 22x. Our testing of
this strategy has identified a tight and cost-effective parameter set
for the use of this approach in C.elegans. We find that analyzing 10-
fold fewer (50) homozygous recombinant pools provides fine-
grained mapping information. In the case presented here, it
provided a ,2 Mb mapping interval and limited the candidate
phenotype causing mutations to only 3 protein changing variants.
Even the analysis of as few as 20 homozygous recombinants
allowed for mapping of the mutation to a ,5 Mb interval with 8
protein-changing variants (compared to an average of 130 protein-
changing variants found all across mutagenized genomes). As
recombination frequency is not uniform throughout the genome
[15], the number of recombinants needed to obtain mapping to a
few megabases will differ on a case by case basis, but we consider
20–50 recombinants a reasonable compromise between amount of
effort needed and mapping resolution.
We also find that the sequencing depth that we currently
employ for standard C.elegans WGS (1 lane of a flow cell, non-
paired 100 nucleotide reads) provides sufficient data to query the
genome for Bristol/Hawaiian SNPs. The approach presented here
can also be used to map a dominant mutation. To this end, one
would need to test which of the individually isolated F2 animals
are homozygous for the mutation by examining their F3 progeny.
Only homozygous F2 animals shall be processed further. The
method can also be used to map a phenotype-causing deletion [5].
Figure 2. ot266 mutant animals show ectopic expression of a dopaminergic cell fate marker. A: The head region of an adult worm is
shown. 4 CEP and 2 ADE neurons express gfp in wild-type animals. The marker is vtIs1 (dat-1::gfp). See Table 1 for quantification. B: VAB-3 protein
structure and location of alleles.
doi:10.1371/journal.pone.0015435.g002
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Recently, Zuryn et al. provided a proof-of-principle study for
another approach to map and clone genes within a single WGS run
[16]. Rather than crossing a mutant C. elegans strain to a
polymorphic mapping strain, the authors backcrossed their mutant
strain with the starting strain used for mutagenesis. Backcrossing
several times eliminated all unlinked mutagen-induced sequence
variants, while linked, mutagen-induced variants remained, thereby
providing mapping information [16]. The Zuryn et al. strategy
requires multiple, non-allelic C. elegans strains to eliminate
background variants through comparing WGS datasets [16]. The
WGS-SNP-based strategy described here does not involve compar-
ing different WGS datasets (and therefore works with individual
mutants), does not require the availability of the starting C. elegans
strain for outcrossing, and it requires only a single cross. However, it
does require the availability of a reasonably well-characterized
polymorphic strain, such as the Hawaiian CB4856 strain.
As pointed out before [9], the combined SNP/WGS strategy
that we describe here for C. elegans, can of course be applied for
mutant identification in many other model system species in which
positional cloning has traditionally been tedious.
Materials and Methods
Strains
The following strains were use: Hawaiian strain CB4856 [10],
BY200 vtIs1[dat-1::gfp; rol-6(d)], OH4254 ot266; vtIs1[dat-1::gfp; rol-
6(d)], OH4330 ot292;vtIs1[dat-1::gfp;rol-6(d)], CB648 vab-3(e648).
RNAi was performed on a sensitized background strain, OH9315
(eri-1; lin-15b; vtIs1).
Genetic screen and RNAi
OH4254 animals were mutagenized with EMS and were kept at
25uC at all times. 5 parental (P0) mutagenized animals were placed
in each of 10 founder P0 plates. Three days later, 400 F1 progeny
of the mutagenized P0 animals were singled. Their ensuing
progeny (F2 and F3 generation) were screened under a
stereomicroscope equipped with a fluorescent light source and
individual mutant animals were picked to establish mutant lines.
For recapitulating the vab-3 phenotype with RNAi we plated L3
stage, eri-1; lin-15b; vtIs1 worms on plates coated with bacteria
expressing a vab-3 dsRNA clone and scored the F1 progeny for gfp
expression from the vtIs1 transgene.
Mapping cross and DNA preparation
We crossed ot266 animals with Hawaiian CB4856 males and
singled F1 cross progeny. In the F2 progeny, we picked 20 (or 50)
progeny with the Dopy phenotype and singled them onto
individual plates. We allowed the F2 recombinants to self fertilize
until they filled 6 cm plates. We pooled the progeny of 20 (or 50)
F2 animals, using approximately similar numbers of animals from
each plate. The pooled worms were lysed and genomic DNA was
prepared according to the standard protocol used for sample
preparation for WGS (http://biochemistry.hs.columbia.edu/labs/
hobert/protocols.html). DNA libraries were prepared according to
Illumina’s protocol. The pooled DNA from each experiment was
then subjected to WGS on an Illumina GA2 sequencing platform,
using single 100 nucleotide reads.
Data analysis with MAQGene
To run MAQGene we used the general parameters previously
described [12] setting ‘‘max sum of error qualities for mapping
assembly and pileup’’ to 200. To call a variant we used the
following general criteria: loci multiplicity ,=1, total sequencing
depth .=3, consensus quality score .=3, neighboring score
.=3, and fraction of non-wt reads .=0.8.
For identifying the mapping interval, MAQGene was modified
to generate an additional output file that provides a pileup for all










Wild type 0% 0% 0% 0% .100
vab-3(ot266) 88% 49% 28% 9% 43
vab-3(ot292) 76% 53% 18% 2% 51
vab-3(e648) 88% 40% 21% 17% 48
vab-3(RNAi) 2 20% 17.5% 2.5% 0% 40
1Percentage of animals with ectopic dat-1::gfp (vtIs1) expression.
2RNAi was performed in a genetically sensitized strain background, eri-1; lin-15b [17] (see Material and Methods).
doi:10.1371/journal.pone.0015435.t001






















50 2 41x 8841415–10975250 (0.43 to 2.77 cM) 2.13 2.34 3
50 1 (lane #1) 20x 8908053–10975250 (0.44 to 2.77 cM) 2.06 2.33 3
50 1 (lane #2) 20x 8841415–11698279 (0.43 to 6.16 cM) 2.85 5.70 7
20 1 18x 6056881–10981227 (23.78 to 2.78 cM) 4.90 6.56 9
doi:10.1371/journal.pone.0015435.t002
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annotated SNP loci, the number of Bristol reads, the number of
Hawaiian reads and the sequencing depth. This file contains all
annotated SNPs in the Bristol genome and needs to be filtered
using, for example, Microsoft Excel to include only Hawaiian
SNPs (named as haw). Using this file we calculated the ratio of
Hawaiian (HA) reads in Excel (ratio of HA reads = number of HA
reads/total number of reads). To minimize the chance that
random sequencing errors would falsely appear as HA sequence in
Figure 3. Application of the WGS-SNP strategy for mapping and cloning ot266. Red arrow indicates the phenotype-causing mutation in
vab-3(ot266). Numbers next to the chromosomes depict how many SNP loci show occurrence of Hawaiian SNPs in the 0.2–0.6 range (see Material and
Methods for explanation of this range). Note that the mapping interval obtained from the 50 recombinants, lane 1 dataset is smaller than the one
defined from 50 recombinants, two lanes dataset (see also Table 2). We believe that this is due to random variability in sample representation in the
flow cell. Also note that this dataset does not allow to easily infer the position of the vtIs1 transgene since we did not select for homozygous vtIs1
animals in the F2 generation.
doi:10.1371/journal.pone.0015435.g003
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SNP loci, we did not consider loci with very low occurrence of HA
sequences. In particular, we filtered the dataset to include only
SNPs with at least 3 HA reads and a HA ratio of at least 0.2. In
addition, we did not include in our analysis SNPs with ratios of
HA sequences above 0.6. The reason for this upper ‘cutoff’ is the
existence of loci annotated as SNPs in the Bristol genome that we
actually found to be (in multiple Bristol based sequenced strains)
identical to the Hawaiian annotated sequence for this locus. Thus,
these loci (a few hundred in total) are ‘falsely’ annotated SNPs,
possibly representing Bristol sequencing errors or loci of
heterozygosity and are not indicative of the actual existence of
Hawaiian sequences in a region. We excluded these loci from our
datasets by filtering out everything that appeared too high on
Hawaiian ratios (above 0.6). We have compiled a list with SNP loci
that in two or more of our Bristol datasets show HA sequence
(Table S2).
We then checked the distribution of SNPs that fulfilled the
above filtering criteria across the six chromosomes. We did that by
using an Adobe Illustrator XY scatter plot to graphically represent
for each chromosome the physical location of each SNP (Fig. 3).
Chromosome X was immediately revealed as the mutation-
bearing chromosome from the existence of an extensive region
devoid of HA SNPs (Fig. 3). The mapping region was defined by
the physical location of the two consecutive HA SNPs located the
furthest apart from each other. As an alternative way of
representing the data, we generated an XY scatter plot of the
position of the SNPs in which the ratio of HA sequence
representation over the total sequencing depth is also depicted
(Fig.4). For this plot, the same general filtering criteria described
above were used.
For identifying the molecular lesion of the mutant, we filtered in
Microsoft Excel the variant MAQGene output file for protein
changing variants. In particular we filtered the class of mutations
to fulfill the following conditions: [does not contain ‘SNP’] AND
([contains ‘missense’] OR [contains ‘stop’] OR [contains ‘donor’]
OR [contains ‘acceptor’]).
We did not filter out common variants that appear in our
previously sequenced datasets as the resolution of this method does
not require comparison with additional datasets.
MAQGene modification
The aforementioned new SNP-specific output file contains one
line per known SNP location with the following fields: chromo-
some, position, snp name, snp base, number of snp-containing
reads, reference base, number of reference-containing reads, total
number of reads.
In order to produce this extra results file, we added one step to
MAQGene’s database building part and one to the pipeline itself.
The database building step is necessary because the previous
version, which extracts all of its annotation information from
ftp.wormbase.org/pub/wormbase/genomes/c_elegans/genome_
feature_tables/GFF3/c_elegans.WS201.gff3.gz lacks actual SNP




During the pipeline itself, the pileup file (already produced
routinely) is scanned a second time to extract all positions of
known SNPs, regardless of low sequencing coverage or other filters
that are applied in the main results file. Together with the new
information about actual SNP base, the number of reads matching
either the SNP base or reference base are counted and reported in
a separate tabular text file.
Figure 4. Alternative graphic representation of the WGS-SNP
data. The WGS SNP data is shown for Chromosome X, 50
recombinants, 2 sequencing lanes. The positions of SNP loci are
depicted as a XY scatter plot, where the ratio ‘Hawaiian/total number of
reads for each SNP is represented. The red line indicates the position of
the phenotype-causing variant. 3 different filtering criteria were used, as
indicated in the figure. Note that the non-linear appearance of the right
arm of the scatter plot reflects the increased recombination rate on that
part of the chromosome (as can be visualized by Marey map for CHR X –
data not shown). Using 0.1–0.8 filtering criteria, narrowed down the
mapping interval even further (1.57 Mb).
doi:10.1371/journal.pone.0015435.g004
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As usual, users interested in this extra feature must update their
installation of MAQGene and re-run the database building step
(build_annotation_tables.sh).
Supporting Information
Table S1 List of mutations in the mapping region. (DOCX)
Table S2. Bristol SNP loci with Hawaiian sequence. (XLS)
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